GSK PLC

Historical 13F Holders

Symbol
GSK
CUSIP
37733W204
All holders as of
Q2 2026
Type
Equity
Class
SPONSORED ADR
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 37733W204 since 12/18/2024, largest first.

Filer % of Class Filed
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Dodge & Cox 13G/A 4.3% 8/13/2026
Event 6/30/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 320 15.0 M $721 M
2026 Q2 1,092 347 M $18.2 B
2026 Q1 1,073 374 M $20.7 B
2025 Q4 1,031 398 M $19.5 B
2025 Q3 936 388 M $16.8 B
2025 Q2 935 386 M $14.8 B
2025 Q1 899 365 M $14.1 B
2024 Q4 893 341 M $11.5 B
2024 Q3 943 309 M $12.6 B
2024 Q2 922 322 M $12.4 B
2024 Q1 945 336 M $14.4 B
2023 Q4 939 304 M $11.2 B
2023 Q3 894 285 M $9.90 B
2023 Q2 863 277 M $9.86 B
2023 Q1 852 273 M $9.69 B
2022 Q4 858 284 M $10.3 B
2022 Q3 765 265 M $7.80 B
2022 Q2 68 4.25 M $185 M
2022 Q1 8 52.7 k $2.30 M
2021 Q4 8 60.7 k $2.68 M
2021 Q3 8 17.8 k $687 k
2021 Q2 7 17.6 k $708 k
2021 Q1 7 18.4 k $664 k
2020 Q4 5 7.65 k $281 k
2020 Q3 5 8.44 k $317 k
2020 Q2 4 8.44 k $344 k
2020 Q1 4 8.86 k $334 k
2019 Q4 4 9.06 k $426 k
2019 Q3 3 6.48 k $277 k
2019 Q2 2 6.01 k $241 k
2019 Q1 3 6.10 k $255 k
2018 Q4 3 7.50 k $287 k
2018 Q3 3 8.13 k $327 k
2018 Q2 3 17.0 k $686 k
2018 Q1 3 17.0 k $665 k
2017 Q4 3 16.8 k $595 k
2017 Q3 3 18.1 k $735 k
2017 Q2 3 20.8 k $897 k
2017 Q1 3 20.8 k $877 k
2016 Q4 3 20.9 k $803 k
2016 Q3 3 16.2 k $697 k
2016 Q2 3 15.9 k $690 k
2016 Q1 3 17.2 k $698 k
2015 Q4 1 183 $7.38 k
2015 Q3 1 168 $6.46 k
2015 Q2 1 168 $7.00 k
2015 Q1 1 129 $5.95 k
2014 Q4 1 129 $5.51 k
2014 Q3 1 129 $5.93 k
2014 Q2 1 100 $5.35 k
2014 Q1 1 100 $5.34 k